Atlantic Journal Logo
Atlantic Journalof Life Sciences
Back to Articles

Plasma Homocysteine levels and cardiovascular risk Profiles in Adults with cardiovascular Disease: A retrospective observational study in Morocco

Peer-reviewed article overview and publication details.

October 21, 2026kholoud krimi, Dounia El Moujtahide, El-houcine Sebbar, Mohammed ChoukriPublishedOriginal research

Abstract

Homocysteine may contribute to vascular injury and cardiovascular disease. This study described plasma homocysteine concentrations in 52 adults with cardiovascular or thromboembolic diseases at Mohammed VI University Hospital of Oujda, Morocco. Patients underwent homocysteine testing between January 2019 and July 2024. Clinical and laboratory data were analyzed descriptively according to age, sex, cardiovascular risk factors, vitamin status, and diagnosis. Mean age was 51.34 years; 28 patients were men. Mean homocysteine concentrations increased with age, from 5.5 μmol/L in patients younger than 20 years to 20.40 μmol/L in those older than 60 years. Concentrations were higher in women than men (16.87 vs 14.98 μmol/L) and highest in patients with hypertension (24.85 μmol/L). Vitamin B9 and B12 deficiencies were associated with slightly higher concentrations. These findings suggest age- and risk-factor-related variation; however, the descriptive design and lack of a control group preclude causal conclusions.

Keywords

Homocysteine; Hyperhomocysteinemia; Cardiovascular diseases; Hypertension; Vitamin B deficiency.

DOI

10.71005/ehs25810

Last Updated

October 21, 2026

Copyright

Atlantic Journal of Life Sciences (2026)

Pages

Not provided

References

  1. African Journal of Neurological Sciences. (2009). African Journal of Neurological Sciences, 28(1).
  2. Allen, R. H., Stabler, S. P., Savage, D. G., & Lindenbaum, J. (1993). Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. The FASEB Journal, 7(14), 1344–1353. https://doi.org/10.1096/fasebj.7.14.7901104
  3. Boushey, C. J., Beresford, S. A. A., Omenn, G. S., & Motulsky, A. G. (1995). A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA, 274(13), 1049–1057. https://doi.org/10.1001/jama.1995.03530130055028
  4. Buysschaert, M., Dramais, A. S., Wallemacq, P. E., & Hermans, M. P. (2000). Hyperhomocysteinemia in type 2 diabetes: Relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care, 23(12), 1816–1822. https://doi.org/10.2337/diacare.23.12.1816
  5. Chico, A., Perez, A., Cordoba, A., Arcelus, R., Carreras, G., de Leiva, A., et al. (1998). Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: A new link between diabetic nephropathy and cardiovascular disease? Diabetologia, 41(6), 684–693. https://doi.org/10.1007/s001250050969
  6. Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., et al. (1991). Hyperhomocysteinemia: An independent risk factor for vascular disease. New England Journal of Medicine, 324(17), 1149–1155. https://doi.org/10.1056/NEJM199104253241701
  7. den Heijer, M., Koster, T., Blom, H. J., Bos, G. M. J., Briet, E., Reitsma, P. H., et al. (1996). Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine, 334(12), 759–762. https://doi.org/10.1056/NEJM199603213341203
  8. Elguedri, S., Ben Khalifa, F., Elamouri, B., Oueslati, I., Oueslati, S., Hachicha, H., et al. (2014). Metabolic syndrome and homocysteine. Annales d’Endocrinologie, 75(5–6), 466. https://doi.org/10.1016/j.ando.2014.07.664
  9. Emoto, M., Kanda, H., Shoji, T., Kawagishi, T., Komatsu, M., Mori, K., et al. (2001). Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care, 24(3), 533–538. https://doi.org/10.2337/diacare.24.3.533
  10. Goldstein, M., Leibovitch, I., Yeffimov, I., Gavendo, S., Sela, B. A., & Loewenstein, A. (2004). Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy. Eye, 18(5), 460–465. https://doi.org/10.1038/sj.eye.6700702
  11. Homocysteine Lowering Trialists’ Collaboration. (1998). Lowering blood homocysteine with folic acid-based supplements: Meta-analysis of randomised trials. BMJ, 316(7135), 894–898.
  12. Hvas, A. M., & Nexo, E. (2006). Diagnosis and treatment of vitamin B12 deficiency: An update. Haematologica, 91(11), 1506–1512.
  13. Khedher, M., Said, F., Hamzaoui, A., Khanfir, M., & Houman, M. H. (2018). Variation in homocysteinemia during venous thrombosis: A study of 1045 cases of thrombosis. La Revue de Médecine Interne, 39(Suppl. 1), A131. https://doi.org/10.1016/j.revmed.2018.03.049
  14. Laraqui, A., Allami, A., Carrie, A., Coiffard, A. S., Benkouka, F., Benjouad, A., et al. (2007). Relation between plasma homocysteine, gene polymorphisms of homocysteine metabolism-related enzymes, and angiographically proven coronary artery disease. European Journal of Internal Medicine, 18(6), 474–483. https://doi.org/10.1016/j.ejim.2007.02.020
  15. Masson, E. (n.d.). Hyperhomocysteinemia in a type 2 diabetic population: Prevalence and association with clinicobiological parameters. EM-Consulte. URL à compléter.
  16. Momin, M., Jia, J., Fan, F., Li, J., Dou, J., Chen, D., et al. (2017). Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population. Lipids in Health and Disease, 16, Article 54. https://doi.org/10.1186/s12944-017-0441-6
  17. Otmane, A., Makrelouf, M., Bouchama, R., Boucelma, M., Berrah, A., & Zenati, A. (2007). Measurement of total homocysteine in a cohort of patients with type 2 diabetes. Revue Francophone des Laboratoires, 2007(396, Suppl. 1), 21–24. https://doi.org/10.1016/S1773-035X(07)80418-7
  18. Paul, J. L., & Baudin, B. (2009). Pathophysiology of atherosclerosis and early markers. Revue Francophone des Laboratoires, 2009(409), 41–50. https://doi.org/10.1016/S1773-035X(09)70199-6
  19. Ross, R. (1999). Atherosclerosis—An inflammatory disease. New England Journal of Medicine, 340(2), 115–126. https://doi.org/10.1056/NEJM199901143400207
  20. Selhub, J., Jacques, P. F., Rosenberg, I. H., Rogers, G., Bowman, B. A., Gunter, E. W., et al. (1999). Serum total homocysteine concentration in the third National Health and Nutrition Examination Survey, 1991–1994: Population reference ranges and contribution of vitamin status to high serum concentrations. Annals of Internal Medicine, 131(5), 331–339.
  21. Selhub, J., Jacques, P. F., Wilson, P. W., Rush, D., & Rosenberg, I. H. (1993). Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA, 270(22), 2693–2698. https://doi.org/10.1001/jama.1993.03510220049033
  22. Shaikh, M. K., Devrajani, B. R., Shaikh, A., Shah, S. Z. A., Shaikh, S., & Singh, D. (2012). Plasma homocysteine level in patients with diabetes mellitus. World Applied Sciences Journal, 16(9), 1269–1273.
  23. Stabler, S. P., Lindenbaum, J., Savage, D. G., & Allen, R. H. (2013). Metabolic profiling of total homocysteine and related compounds in hyperhomocysteinemia: Utility and limitations in diagnosing the cause of puzzling thrombophilia in a family. In J. Zschocke, K. M. Gibson, G. Brown, E. Morava, & V. Peters (Eds.), JIMD Reports—Volume 11 (pp. 149–163). Springer. https://doi.org/10.1007/8904_2013_235
  24. Sun, J., Han, W., Wu, S., Jia, S., Yan, Z., Guo, Y., et al. (2021). Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults ≤35 years of age: A hospital-based observational study. BMC Cardiovascular Disorders, 21(1), Article 484. https://doi.org/10.1186/s12872-021-02302-0
  25. Tucker, K. L., Selhub, J., Wilson, P. W., & Rosenberg, I. H. (1996). Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study. The Journal of Nutrition, 126(12), 3025–3031. https://doi.org/10.1093/jn/126.12.3025
  26. Wang, Y., Chen, S., Yao, T., Li, D., Wang, Y., Li, Y., et al. (2014). Homocysteine as a risk factor for hypertension: A 2-year follow-up study. PLOS ONE, 9(10), Article e108223. https://doi.org/10.1371/journal.pone.0108223
  27. World Health Organization. (2014). Global status report on noncommunicable diseases 2014. https://www.who.int/publications-detail-redirect/9789241564854
  28. Zerrouk, F. (2023). Impact of hyperhomocysteinemia on cardiovascular diseases in a murine model [Dissertation, Mouloud Mammeri University of Tizi Ouzou].
  29. Zhang, Z. Y., Jiang, Y. Y., Wang, Z., Li, L., Shi, W., Ji, J. G., et al. (2021). Homocysteine, hypertension, and risks of cardiovascular events and all-cause death in the Chinese elderly population: A prospective study. Journal of Geriatric Cardiology, 18(10), 796–808. https://doi.org/10.11909/j.issn.1671-5411.2021.10.005

Read Article

Render the article on this page with its figures and layout, or download the PDF.

Full text PDF

Citation

American Psychological Association

krimi, K., El Moujtahide, D., Sebbar, E., and Choukri, M. (2026). Plasma Homocysteine levels and cardiovascular risk Profiles in Adults with cardiovascular Disease: A retrospective observational study in Morocco. Atlantic Journal of Life Sciences. https://doi.org/10.71005/ehs25810